Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
5.01
+0.39 (8.44%)
At close: Jun 6, 2025, 4:00 PM
5.04
+0.03 (0.60%)
After-hours: Jun 6, 2025, 6:08 PM EDT

Monte Rosa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
6.15-72.7-135.35-108.5-73.96-35.88
Upgrade
Depreciation & Amortization
10.1710.228.323.752.130.54
Upgrade
Loss (Gain) From Sale of Assets
-0.06--0.02-0.110.02-
Upgrade
Loss (Gain) From Sale of Investments
-3.91-2.95-3.78-1.95--
Upgrade
Stock-Based Compensation
18.5518.1316.6711.665.20.35
Upgrade
Other Operating Activities
-1.9-2.1-2.14.810.967.68
Upgrade
Change in Accounts Receivable
-0.890.331.9-0.19--
Upgrade
Change in Accounts Payable
0.456.255.76-0.74-0.713.44
Upgrade
Change in Unearned Revenue
0.583.3850---
Upgrade
Change in Other Net Operating Assets
5.61.4414.81-1.26.990.82
Upgrade
Operating Cash Flow
34.6742-43.8-92.47-59.36-23.05
Upgrade
Capital Expenditures
-4.19-3.99-19.04-12.91-9.73-3.39
Upgrade
Sale of Property, Plant & Equipment
--0.060.110.08-
Upgrade
Investment in Securities
-150.34-40.46107.78-206.42--
Upgrade
Investing Cash Flow
-154.53-44.4588.8-219.22-9.65-3.39
Upgrade
Issuance of Common Stock
52.352.532.6121.45255.79-
Upgrade
Other Financing Activities
46.3646.3624.88-0.98-21.23-0.44
Upgrade
Financing Cash Flow
98.6698.8927.4920.47377.5660.06
Upgrade
Net Cash Flow
-21.2196.4472.49-291.22308.5533.62
Upgrade
Free Cash Flow
30.4838.01-62.84-105.38-69.1-26.44
Upgrade
Free Cash Flow Margin
19.11%50.26%----
Upgrade
Free Cash Flow Per Share
0.380.51-1.22-2.23-2.76-17.43
Upgrade
Levered Free Cash Flow
40.5481.97-53.37-72.4-61.297.6
Upgrade
Unlevered Free Cash Flow
40.5481.97-53.37-72.4-61.297.6
Upgrade
Change in Net Working Capital
-17.34-108.31-30.254.6613.34-27.61
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q